Literature DB >> 3879167

Effect of acyclovir on mammalian embryonic development in culture.

S Klug, C Lewandowski, G Blankenburg, H J Merker, D Neubert.   

Abstract

Acyclovir [9-(2-hydroxyethoxymethyl)guanine] interfered with embryonic development in vitro when assessed with the "whole-embryo" culture technique. The "no-observed-effect level" was at 10 microM acyclovir; Minor impairment of embryonic development (retarded development of ear anlagen) was observed in vitro at 25 microM acyclovir in the culture medium. At high concentrations (100 or 200 microM) development of the ear anlagen was largely inhibited. At concentrations of 50 microM acyclovir or higher, additional disturbances of embryonic differentiation in vitro became obvious, resulting in gross structural abnormalities, especially of the brain (telencephalon); Histological examinations confirmed and extended these observations: at 100 microM acyclovir alterations of the neuroepithelium of the ventricles were pronounced, the telencephalon had developed poorly or was almost completely absent, and necroses were seen in the ear anlagen, the maxillary branch and within the somites; In a limb bud culture (mouse embryos, starting with day 11 of gestation) acyclovir interfered with the differentiation of cartilaginous bone anlagen at concentrations of 200 microM and more in the culture medium. A concentration of 100 microM induced no significant effect. Thus, this organ culture system is less sensitive to the action of acyclovir when compared with whole-embryo culture; Contrary to the results achieved with acyclovir, physiological nucleosides (2'-deoxyguanosine and 2'-deoxyadenosine) did not interfere with embryonic development in vitro even at the highest concentration tested (500 microM).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3879167     DOI: 10.1007/bf00348315

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  15 in total

1.  Comparison of in vitro and in vivo development of rat foetuses.

Authors:  D L Cockroft
Journal:  Dev Biol       Date:  1976-01       Impact factor: 3.582

2.  In vitro system for toxicological studies on the development of mammalian limb buds in a chemically defined medium.

Authors:  U Lessmöllmann; N Hinz; D Neubert
Journal:  Arch Toxicol       Date:  1976-10-28       Impact factor: 5.153

3.  In vitro susceptibility of varicella-zoster virus to acyclovir.

Authors:  K K Biron; G B Elion
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

4.  The genotoxic potential of bases and nucleosides.

Authors:  D Anderson; C R Richardson; P J Davies
Journal:  Mutat Res       Date:  1981-05       Impact factor: 2.433

5.  Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate.

Authors:  P A Furman; M H St Clair; J A Fyfe; J L Rideout; P M Keller; G B Elion
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

6.  Acyclovir kinetics after intravenous infusion.

Authors:  P de Miranda; R J Whitley; M R Blum; R E Keeney; N Barton; D M Cocchetto; S Good; G P Hemstreet; L E Kirk; D A Page; G B Elion
Journal:  Clin Pharmacol Ther       Date:  1979-12       Impact factor: 6.875

Review 7.  Overview of acyclovir pharmacokinetic disposition in adults and children.

Authors:  M R Blum; S H Liao; P de Miranda
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

8.  Preclinical toxicology studies with acyclovir: acute and subchronic tests.

Authors:  W E Tucker; A W Macklin; R J Szot; R E Johnston; G B Elion; P de Miranda; G M Szczech
Journal:  Fundam Appl Toxicol       Date:  1983 Nov-Dec

9.  Preclinical toxicology studies with acyclovir: teratologic, reproductive and neonatal tests.

Authors:  H L Moore; G M Szczech; D E Rodwell; R W Kapp; P de Miranda; W E Tucker
Journal:  Fundam Appl Toxicol       Date:  1983 Nov-Dec

10.  Metabolism of acyclovir in virus-infected and uninfected cells.

Authors:  P A Furman; P de Miranda; M H St Clair; G B Elion
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

View more
  8 in total

1.  Effects of valproic acid, some of its metabolites and analogues on prenatal development of rats in vitro and comparison with effects in vivo.

Authors:  S Klug; C Lewandowski; F Zappel; H J Merker; H Nau; D Neubert
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  Teratogenicity of acyclovir in rats.

Authors:  R Stahlmann; S Klug; C Lewandowski; I Chahoud; G Bochert; H J Merker; D Neubert
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

3.  Gross-structural defects in rats after acyclovir application on day 10 of gestation.

Authors:  I Chahoud; R Stahlmann; G Bochert; I Dillmann; D Neubert
Journal:  Arch Toxicol       Date:  1988-08       Impact factor: 5.153

4.  Prenatal toxicity of acyclovir in rats.

Authors:  R Stahlmann; S Klug; C Lewandowski; G Bochert; I Chahoud; U Rahm; H J Merker; D Neubert
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

5.  Effect of aciclovir on the development of the chick embryo in ovo.

Authors:  B Heinrich-Hirsch; D Neubert
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

6.  In vitro and in vivo studies on the prenatal toxicity of five virustatic nucleoside analogues in comparison to aciclovir.

Authors:  S Klug; C Lewandowski; H J Merker; R Stahlmann; L Wildi; D Neubert
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

7.  Abnormal thymus development and impaired function of the immune system in rats after prenatal exposure to aciclovir.

Authors:  R Stahlmann; M Korte; H Van Loveren; J G Vos; R Thiel; D Neubert
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

8.  Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model.

Authors:  Michael Melnick; Edward S Mocarski; George Abichaker; Jing Huang; Tina Jaskoll
Journal:  BMC Dev Biol       Date:  2006-09-07       Impact factor: 1.978

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.